Drilldown: Medicines
Medicines > fda max 
:
6 mg/d (psychosis/mania); 3 mg/d (depression adjunct) or
600 mg/d
& routes:
Oral
:
6 mg/d (psychosis/mania); 3 mg/d (depression adjunct) or
600 mg/d
& routes:
Oral Use the filters below to narrow your results.
generic:
classes:
mechanism:
uses:
Schizophrenia (FDA-approved 2015). Acute manic or mixed episodes of bipolar I disorder. Bipolar I depression (FDA-approved 2019). Adjunctive treatment of major depressive disorder (FDA-approved Dec 2022). (1) ·
'"`UNIQ--vote-000009DF-QINU`"', '"`UNIQ--vote-000009E0-QINU`"', '"`UNIQ--vote-000009E1-QINU`"', '"`UNIQ--vote-000009E2-QINU`"', '"`UNIQ--vote-000009E3-QINU`"' (1)
starting dose:
preparations:
fda max: (Click arrow to add another value)
routes: (Click arrow to add another value)
duration:
halflife:
bioavailability:
pregnancy:
Showing below up to 2 results in range #1 to #2.